Vitals Knowledge Vault

Endothelial Function

4 min read

Endothelial Function

TL;DR

Endothelial function refers to the ability of the vascular endothelium (the single-cell lining of all blood vessels) to produce and release nitric oxide and other vasodilatory, anti-inflammatory, and antithrombotic mediators in response to physiological demand. Dysfunction — characterized by reduced NO bioavailability, increased oxidative stress, and a pro-inflammatory endothelial phenotype — is one of the earliest detectable stages of atherosclerotic and metabolic vascular disease. It is measurable via flow-mediated dilation (FMD), arterial stiffness (PWV), and related metrics.

Why It Matters for Vitals

Endothelial function is the common vascular pathway through which many Vitals-relevant interventions exert their cardiovascular benefits: dietary nitrates (beetroot), exercise, GLP-1 RAs, SGLT2 inhibitors, cocoa flavanols, and metformin all independently improve endothelial function via distinct mechanisms. Tracking FMD and arterial stiffness alongside blood pressure provides a more complete picture of vascular health than BP alone, especially for older adults and patients with metabolic syndrome.

Core Biology

Healthy Endothelium

  • Produces nitric oxide (NO) via endothelial nitric oxide synthase (eNOS) in response to shear stress
  • Releases prostacyclin (PGI₂) — vasodilatory and antiplatelet
  • Expresses antithrombotic surface molecules (heparan sulfate, thrombomodulin)
  • Maintains anti-inflammatory state via reduced adhesion molecule expression (VCAM-1, ICAM-1, E-selectin)

eNOS-NO Pathway

Shear stress → PI3K/Akt → eNOS phosphorylation (Ser1177) → increased NO production → smooth muscle relaxation → vasodilation. This is the primary acute endothelial response mechanism. It is oxygen-dependent and becomes impaired under oxidative stress.

Endothelial Dysfunction

Hallmarks:

  • Reduced NO bioavailability (decreased production or increased inactivation by superoxide)
  • Increased reactive oxygen species (ROS) — particularly superoxide (O₂⁻)
  • Increased adhesion molecule expression → leukocyte adhesion and vascular inflammation
  • Increased endothelial permeability → LDL particle entry and subintimal retention
  • Prothrombotic phenotype

eNOS Uncoupling

Under oxidative stress (elevated superoxide), the eNOS enzyme becomes “uncoupled”: instead of producing NO, it generates superoxide. This shifts the enzyme from vasoprotective to pro-oxidant, accelerating endothelial dysfunction. The FAD and BH4 cofactors are particularly sensitive to oxidation. See eNOS uncoupling for full detail.

Measurement

Flow-Mediated Dilation (FMD)

  • Gold standard clinical measure of endothelial function
  • Reactive hyperemia-induced shear stress → brachial artery dilation measured by ultrasound
  • Expressed as % change from baseline diameter
  • Normal: >5–7%; impaired: 2–5%; severely impaired: <2%
  • Beetroot nitrate improves FMD ~0.9–1.2% absolute in both healthy and at-risk populations
  • Low reproducibility in routine practice (requires skilled operator); best for controlled trial settings

Arterial Stiffness — PWV (Pulse Wave Velocity)

  • Measures speed of arterial pressure wave propagation
  • Higher PWV = stiffer arteries
  • Carotid-femoral PWV is the reference standard
  • More reproducible than FMD; more suitable for clinical tracking
  • Age is the dominant predictor; PWV rises ~0.8–1.0 m/s per decade after age 40

Other Surrogates

  • Reactive hyperemia peripheral arterial tonometry (EndoPAT) — less operator-dependent; used in research
  • Laser Doppler flowmetry — microvascular endothelial function; research use only
  • NO metabolite levels (nitrite/nitrate in blood) — too variable for clinical use

Vitals Compound Relevance

InterventionEndothelial EffectMechanism
Beetroot NitrateFMD ↑0.9–1.2% absolute; SBP ↓4–8 mmHgNitrate-nitrite-NO pathway; oxygen-independent NO generation
Cocoa FlavanolsFMD ↑0.5–1.0%; BP modest ↓Antioxidant; reduced NO oxidative inactivation
Acute aerobic exerciseAcute FMD improvement; chronic eNOS upregulationShear stress → eNOS activation
SGLT2 InhibitorsFMD improvement; PWV reduction reportedKetone body signaling; reduced oxidative stress
GLP-1 RAs (semaglutide, tirzepatide)FMD improvement; endothelial adhesion molecule reductionReduced systemic inflammation; indirect effects
MetforminModest FMD improvementAMPK activation; reduced oxidative stress
NMN NAD+Preclinical eNOS improvementNAD+ restoration → sirtuin-mediated eNOS activation

Confounders of Endothelial Function Assessment

  • Smoking — acute and chronic impairment
  • Hyperglycemia — ROS-mediated NO inactivation
  • Hyperlipidemia — oxidized LDL impairs endothelial function
  • Hypertension — both cause and consequence of dysfunction
  • Inflammation (CRP elevation) — TNF-α suppresses eNOS expression
  • Aging — see Vascular Aging
  • Alcohol — J-curve: moderate consumption may improve FMD; excess impairs
  • Sleep deprivation — acute impairment of FMD
  • Antiseptic mouthwash — disrupts oral nitrate → nitrite conversion; indirect effect on endothelial NO
  • Beetroot Nitrate — beetroot nitrate is a dietary nitrate intervention with confirmed FMD benefit
  • eNOS uncoupling — mechanism by which oxidative stress converts eNOS from NO-producing to superoxide-producing
  • Vascular Aging — age-related endothelial decline; primary population context for endothelial interventions
  • Blood Pressure Response Nitrate — systolic BP as the primary wearable-accessible signal for beetroot nitrate
  • HRV — HRV is a separate autonomic signal, not a direct measure of endothelial function
  • Vitals Knowledge Map — vault topic index

Graph View

Backlinks